Immunomodulatory Effects of Α-Tocopherol on the H1n1 Influenza Vaccine: Improving the Potency and Efficacy of the Influenza Vaccine in Aged Mice Publisher Pubmed



Eshraghi Y^{1, 2, 3} ; Vahdani Y⁴ ; Karimi P^{1, 2} ; Abdollahpouralitappeh M^{5, 6} ; Abdoli A⁷ ; Taghizadeh M⁸ ; Mahdavi M^{1, 2, 9, 10} Show Affiliations
Source: Viral Immunology Published:2022

Abstract

Declined immune response is the main cause of decreased potency of the influenza vaccine in the elderly, regardless of virus mutations. Herein, we hypothesized that the addition of ?-tocopherol to the influenza vaccine formulation might increase vaccine potency and efficacy. Hemagglutinin of the H1N1 virus was formulated in Alum and ?-tocopherol, and then aged (16-20-month-old) and young (6-8-week-old) mice were immunized subcutaneously two times with 2-week intervals with 5 ?g of different vaccine formulations. Two weeks after the final boosting, IFN-?and IL-4 cytokines were assessed by using ELISA. Humoral immune responses were assessed by hemagglutination inhibition (HI). In addition, vaccine efficacy was determined by intranasal viral challenge of mice using mouse-adapted H1N1 virus. Our results showed that the new vaccine formulation improved IFN-?and IL-4 responses in the experimental mice. However, the increase was evident mainly in the aged group and, to some extent, in the young group. Results from the HI assay showed that ?-tocopherol in the vaccine formulation could increase HI activity in both young and aged mice. Furthermore, ?-tocopherol, as an adjuvant, increased the protectivity of the influenza vaccine in both aged and young groups through the decreased lung viral load and increased survival rate of the experimental mice. In conclusion, it seems that ?-tocopherol can not only be used as an appropriate adjuvant for aged people, but also empower old and worn out cells to increase the effectiveness of the vaccine in the elderly. © 2022, Mary Ann Liebert, Inc., publishers 2022.